
|Articles|November 1, 2002
Supplements and Featured Publications
- Use of Selective COX-2 Inhibitors for Chronic Therapy: The Managed Care Perspective
- Volume 8
- Issue 17 Suppl
Gastrointestinal Outcomes: Evidence for Risk Reduction in Patients Using Coxibs
Author(s)James M. Scheiman, MD
Advertisement
Articles in this issue
almost 23 years ago
Cost-Effective Use of NSAIDs: Issues Pertinent to Coxib Use in Managed Carealmost 23 years ago
CME/CPE Quizalmost 23 years ago
Participating FacultyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Reduction in Food Allergies Found After Guideline-Directed Early Peanut Exposure
2
KEYNOTE-905 Paves the Way for Next Generation of MIBC Trials: Christof Vulsteke, MD, PhD
3
Adding Radioligand Therapy Pluvicto to SOC Cuts Risk of Prostate Cancer Progression or Death 28%, but How Many Doses?
4
FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes
5